StreetInsider.com News Articles

Tempus publishes validation study for FDA-cleared ECG AI model

Thu, 11 Jun 2026 08:30:38 -0400

Tempus AI Inc. (NASDAQ: TEM) announced the publication of a multi-center validation study for its artificial intelligence-enabled electrocardiogram software in Heart Rhythm journal. The software received U.S. Food and Drug Administration clearance in 2024 for predicting one-year risk of atrial fibrillation or flutter.

The study evaluated the Tempus ECG-AF software across three clinical sites, analyzing data from 4,017 patients aged 65 and older with no prior atrial fibrillation history and no pacemaker or defibrillator use. The AI-derived risk score met pre-specified performance thresholds, supporting the FDA clearance of the technology.

Atrial fibrillation is the most common cardiac arrhythmia and is associated with

Tempus publishes validation study for FDA-cleared ECG AI model

Thu, 11 Jun 2026 08:30:38 -0400

Atrial fibrillation is the most common cardiac arrhythmia and is associated with

Tempus Announces Multi-Center Validation of AI-Enabled ECG Model for Predicting Atrial Fibrillation Risk Published in Heart Rhythm

Thu, 11 Jun 2026 08:30:00 -0400

CHICAGO--(BUSINESS WIRE)-- Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine, today announced publication of successful multi-site validation of its software, which received U.S. Food and Drug Administration clearance in 2024 for predicting the one-year risk of atrial fibrillation or flutter (AF). The study, titled "Multi-Center Validation of an Artificial Intelligence-Enabled ECG Model to Predict 1-Year Risk of Atrial Fibrillation or Flutter," was recently published in Heart Rhythm.

AF is the most prevalent cardiac arrhythmia and is associated with an increased risk

Tempus Announces Multi-Center Validation of AI-Enabled ECG Model for Predicting Atrial Fibrillation Risk Published in Heart Rhythm

Thu, 11 Jun 2026 08:30:00 -0400

AF is the most prevalent cardiac arrhythmia and is associated with an increased risk

Tempus Announces Multi-Center Validation of AI-Enabled ECG Model for Predicting Atrial Fibrillation Risk Published in Heart Rhythm

Thu, 11 Jun 2026 08:30:00 -0400

AF is the most prevalent cardiac arrhythmia and is associated with an increased risk

Tempus Announces Multi-Center Validation of AI-Enabled ECG Model for Predicting Atrial Fibrillation Risk Published in Heart Rhythm

Thu, 11 Jun 2026 08:30:00 -0400

AF is the most prevalent cardiac arrhythmia and is associated with an increased risk

Tempus Announces Multi-Center Validation of AI-Enabled ECG Model for Predicting Atrial Fibrillation Risk Published in Heart Rhythm

Thu, 11 Jun 2026 08:30:00 -0400

AF is the most prevalent cardiac arrhythmia and is associated with an increased risk

Tempus Announces Multi-Center Validation of AI-Enabled ECG Model for Predicting Atrial Fibrillation Risk Published in Heart Rhythm

Thu, 11 Jun 2026 08:30:00 -0400

AF is the most prevalent cardiac arrhythmia and is associated with an increased risk

Tempus Announces Multi-Center Validation of AI-Enabled ECG Model for Predicting Atrial Fibrillation Risk Published in Heart Rhythm

Thu, 11 Jun 2026 08:30:00 -0400

AF is the most prevalent cardiac arrhythmia and is associated with an increased risk

Tempus Announces Multi-Center Validation of AI-Enabled ECG Model for Predicting Atrial Fibrillation Risk Published in Heart Rhythm

Thu, 11 Jun 2026 08:30:00 -0400

AF is the most prevalent cardiac arrhythmia and is associated with an increased risk

TD Cowen notes short interest shifts in life science tools stocks

Wed, 10 Jun 2026 10:50:16 -0400